|
U-statistics for Censored Data with Applications SOMNATH DATTA, UNIVERSITY OF LOUISVILLE, United States
Methods to Evaluate the Relationship between Survival Times Nicolae Todor, Cancer Institute "Ion Chiricuta", Romania
Nonlinear Eelliptical Models for Correlated Data Cibele Russo, Universidade de São Paulo, Brazil
Estimating Crude Cumulative Incidences Through Multinomial Logit Regression on Discrete Cause Specific Hazards Federico Ambrogi, University of Milan, Italy
Repeated Measures Analysis with Measurements on Ambiguous Scales Olena Kravchuk, University of Queeensland, Australia
Determination of an Overconsumption's Threshold for the Evaluation of Abuse and Dependence Potential of Drugs Lise Bellanger, Université de Nantes, France
Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials Peter Lane, GlaxoSmithKline, United Kingdom
Developing a Population Predictive Model for Oesophagitis and Gastroduodenal Erosions in Subjects with Uninvestigated Dyspepsia Graham Law, University of Leeds, United Kingdom
Omnibus Tests for Comparison of Competing Risks Yichuan Zhao, Georgia State University, United States
Automatic Beam's Eye View Ahmad-Saher Azizi-Sultan, King Saud University, Saudi Arabia
On Approaches for Modelling Time-Varying Effects in Survival Analysis Anika Buchholz, University of Freiburg, Germany
Breast Cancer Screening Program: A Population Profile of Central Portugal Bruno de Sousa, University of Minho, Portugal
Competing Risks Regression on Time-dependent Covariates for Finding Optimal Chemotherapy Dosages Giuliana Cortese, University of padova, Italy
A Differential Equations Approach to In Vitro - In Vivo Correlation Modelling Clare Gaynor, University College Dublin, Ireland
Latent Class Regression Analysis of Colorectal Cancer Data Wendy Harrison, University of Leeds, United Kingdom
Graphical Methods for Detection of Outlying Observations. Application in Designs of Bioavailability Studies Enachescu Denis, University of Bucharest, Romania
A Time Scaling Approach to Developing an In Vitro-In Vivo Correlation (IVIVC) Model Using A Convolution Based Technique Cian Costello, University College Dublin, Ireland
Modelling the Effect of Accumulating Recurrences and Progression in Bladder Cancer Data Cristina Santamaria, Universidad Politécnica de Valencia, Spain
Estimating the Mean Quality Adjusted Life using Aalen’s Linear Hazards Model Vaman Jalikop, Bangalore University, India
Optimisation Using Response Surface Methodology Applied to a Pharmaceutical Plant Sinead O'Neill, University College Cork, Ireland
Comparison of Completeness Estimates in Cancer Registration – A Simulation Sstudy Irene Schmidtmann, Johannes Gutenberg University Mainz, Germany
Correlation between Claus, Gail and Tyrer-Cuzik Models in a Population-based Cohort Study Aishameriane Schmidt, UFRGS, Brazil
Pharmacogenetic Pathway Analysis of Irinotecan Gary Rosner, The University of Texas M.D. Anderson Cancer Center, United States
Statistical Validity and Power for Testing for Heterogeneous Effects with Quantitative Traits in Pharmacogenetic Studies Todd Nick, Cincinnati Children's Hospital Medical Center, United States
|